• Aranha-Creado, H., Peterson, J. & Huang, P.Y. (1998) Clearance of murine leukaemia virus from monoclonal antibody solution by a hydrophilic PVDF microporous membrane filter. Biologicals, 26, 167172.
  • Bos, O.J., Sunye, D.G., Nieuweboer, C.E., Van Engelenburg, F.A., Schuitemaker, H. & Over, J. (1998) Virus validation of pH 4-treated human immunoglobulin products produced by the Cohn fractionation process. Biologicals, 26, 267276.
  • Curti, A., Tosi, P., Comoli, P., Terragna, C., Ferri, E., Cellini, C., Massaia, M., D’Addio, A., Giudice, V., Di Bello, C., Cavo, M., Conte, R., Gugliotta, G., Baccarani, M. & Lemoli, R.M. (2007) Phase I/II clinical trial of sequential subcutaneous and intravenous delivery of dendritic cell vaccination for refractory multiple myeloma using patient-specific tumour idiotype protein or idiotype (VDJ)-derived class I-restricted peptides. British Journal of Haematology, 139, 415424.
  • Freeman, J.L., Vari, F. & Hart, D.N. (2007) CMRF-56 immunoselected blood dendritic cell preparations activated with GM-CSF induce potent antimyeloma cytotoxic T-cell responses. Journal of Immunotherapy, 30, 740748.
  • Gould, P. (2006) Sipuleucel-T shows partial advantage in prostate cancer. The Lancet Oncology, 7, 710.
  • Hock, B.D., Fearnley, D.B., Boyce, A., McLellan, A.D., Sorg, R.V., Summers, K.L. & Hart, D.N. (1999) Human dendritic cells express a 95 kDa activation/differentiation antigen defined by CMRF-56. Tissue Antigens, 53, 320334.
  • Jalili, A., Ozaki, S., Hara, T., Shibata, H., Hashimoto, T., Abe, M., Nishioka, Y. & Matsumoto, T. (2005) Induction of HM1.24 peptide-specific cytotoxic T lymphocytes by using peripheral-blood stem-cell harvests in patients with multiple myeloma. Blood, 106, 35383545.
  • Lopez, J.A., Bioley, G., Turtle, C.J., Pinzon-Charry, A., Ho, C.S., Vuckovic, S., Crosbie, G., Gilleece, M., Jackson, D.C., Munster, D. & Hart, D.N.J. (2003) Single Step isolation of blood dendritic cells by positive immunoselection. Journal of Immunological Methods, 274, 4761.
  • Radford, K.J., Vari, F. & Hart, D.N. (2005) Vaccine strategies to treat lymphoproliferative disorders. Pathology, 37, 534550.
  • Strobeck, M. (2007) Multiple myeloma therapies. Nature Reviews. Drug Discovery, 6, 181182.
  • Turtle, C.J. & Hart, D.N.J. (2004) Dendritic cells in tumor immunology and immunotherapy. Current Drug Targets, 5, 1739.
  • Vulink, A., Radford, K.J., Melief, C. & Hart, D.N. (2008) Dendritic cells in cancer immunotherapy. Advances in Cancer Research, 99, 363407.